Rheos Medicines
Cambridge, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
GS
Gad SofferNamed on SEC filing
RC
Ryan CohlheppNamed on SEC filing
JD
J. Duncan HiggonsNamed on SEC filing
JB
Jeffrey BluestoneNamed on SEC filing
DM
Dan MatloffNamed on SEC filing
SK
Sanjay KeswaniNamed on SEC filing
Board
AC
CP
SS
Stephen SherwinBoard directorInvestor at Third Rock Ventures
Investors · 1
Reported raises · per SEC filings
Form D private placements$27.5M disclosed across 1 round · 2018
▶$27.5MraisedNov 2018 · 1 investors · BiotechnologyRule 506(b)
▶$27.5MraisedNov 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gad SofferExecutive Officer
- Ryan CohlheppExecutive Officer
- Abbie CelnikerDirector
- J. Duncan HiggonsDirector
- Cary PfefferDirector
- Jeffrey BluestoneDirector
- Dan MatloffExecutive Officer
- Stephen SherwinDirector
- Sanjay KeswaniExecutive Officer, Director
- Amount sold
- $27.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Rheos Medicines's investors?
- Rheos Medicines's investors include Third Rock Ventures.
- How much funding has Rheos Medicines raised?
- Rheos Medicines has disclosed $27.5M raised across 1 round.
- Where is Rheos Medicines headquartered?
- Rheos Medicines is headquartered in Cambridge, US.